BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24029252)

  • 1. New-onset diabetes after transplantation--role of oral glucose tolerance test for diagnosis and study of risk factors.
    Sahay M; Sahay RK; Narayan G;
    Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):897-902. PubMed ID: 24029252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracies of Glycated Hemoglobin, Fructosamine, and Homeostasis Model Assessment of Insulin Resistance in Predicting Impaired Fasting Glucose, Impaired Glucose Tolerance, or New Onset Diabetes After Transplantation.
    Rosettenstein K; Viecelli A; Yong K; Nguyen HD; Chakera A; Chan D; Dogra G; Lim EM; Wong G; Lim WH
    Transplantation; 2016 Jul; 100(7):1571-9. PubMed ID: 26437275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation.
    Tokodai K; Amada N; Haga I; Takayama T; Nakamura A
    Diabetes Res Clin Pract; 2014 Feb; 103(2):298-303. PubMed ID: 24468096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation.
    Hjelmesaeth J; Hagen M; Hartmann A; Midtvedt K; Egeland T; Jenssen T
    Clin Transplant; 2002 Dec; 16(6):389-96. PubMed ID: 12437616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Incretin Hormones After Orthotopic Liver Transplantation.
    Gámán G; Sárváry E; Gelley F; Doros A; Görög D; Fehérvári I; Kóbori L; Wágner L; Máthé Z; Nemes B
    Transplant Proc; 2015 Sep; 47(7):2207-9. PubMed ID: 26361681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation.
    Bayés B; Lauzurica R; Granada ML; Serra A; Bonet J; Fontseré N; Salinas I; Romero R
    Transplantation; 2004 Jul; 78(1):26-30. PubMed ID: 15257035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of insulin resistance after renal transplantation in patients on triple immunosuppressive therapy with cyclosporine, corticosteroids and mycophenolate mofetil.
    Petkovska L; Ivanovski N; Dimitrovski C; Serafimoski V
    Prilozi; 2008 Jul; 29(1):129-39. PubMed ID: 18709005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus After Liver Transplantation.
    Martínez-Díaz-Guerra G; Guadalix S; Aramendi M; Librizzi S; García E; Jiménez C; Hawkins F
    Horm Metab Res; 2016 May; 48(5):325-30. PubMed ID: 26743527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of new onset of diabetes after transplantation in stable renal recipients.
    Shehab-Eldin W; Shoker A
    Nephron Clin Pract; 2008; 110(1):c1-9. PubMed ID: 18654089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin.
    Yates CJ; Fourlanos S; Colman PG; Cohney SJ
    Transplantation; 2013 Oct; 96(8):726-31. PubMed ID: 23902993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.
    Ramesh Prasad GV; Huang M; Bandukwala F; Nash MM; Rapi L; Montada-Atin T; Meliton G; Zaltzman JS
    Clin Nephrol; 2009 Feb; 71(2):140-6. PubMed ID: 19203506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P; Ravindran V; Morris-Stiff G; Baboolal K
    Transpl Int; 2013 Mar; 26(3):273-80. PubMed ID: 23230898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
    Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
    Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
    PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT.
    Iida S; Ishida H; Tokumoto T; Omoto K; Shirakawa H; Shimizu T; Amano H; Setoguchi K; Nozaki T; Toki D; Tokita D; Tanabe K
    Int Urol Nephrol; 2010 Dec; 42(4):935-45. PubMed ID: 20169408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Pre- and Post-Transplant Oral Glucose Tolerance Tests: Identifying Kidney Transplant Recipients With or at Risk of New Onset Diabetes After Transplant.
    Singer J; Aouad LJ; Wyburn K; Gracey DM; Ying T; Chadban SJ
    Transpl Int; 2022; 35():10078. PubMed ID: 35368638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.